Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

NCT07248956 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Hypopharyngeal Carcinoma

Interventions

DRUG: Finolizumab
DRUG: Albumin-Bound Paclitaxel /nab-Paclitaxel
DRUG: Cisplatin
RADIATION: Definitive radiotherapy
PROCEDURE: Surgery with postoperative radiotherapy or chemoradiotherapy.

Sponsor

Eye & ENT Hospital of Fudan University